A novel extracellular CD147 drug conjugate significantly inhibits HNSCC [70]; in particular, EDC22 linked with a small-molecule inhibitor of the Na/K-ATPase was evaluated as an extracellular drug conjugate for the monoclonal antibody targeting of CD147. The gene discussed is BSG; the disease is head and neck squamous cell carcinoma.